Madrigal Pharmaceuticals has secured conditional marketing authorization for Rezdiffra, its treatment for a serious liver condition, from regulators in Europe. The biopharmaceutical company said ...

Rezdiffra is the first and only medication approved for people living with MASH in the European Union  Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO ...